Patanjali Foods shares were in focus on Thursday after the Delhi High Court barred Patanjali Ayurved from airing advertisements that allegedly disparage Dabur India’s Chyavanprash. The order comes as part of an ongoing legal battle between the two companies over misleading claims in Patanjali’s promotional campaigns.
The High Court, while granting interim relief to Dabur, observed that the contested ads appeared to amount to prima facie disparagement. The matter will now be heard next on July 14. A detailed written order is awaited.
The dispute began in December 2023, when Dabur filed a suit alleging that Patanjali’s advertisements falsely claimed superiority by stating it used over 51 herbs, while dubbing Dabur’s product “ordinary.” Dabur also accused Patanjali of using mercury in its formulation, rendering it unfit for children—an allegation Patanjali has denied.
While Patanjali Ayurved is not listed, the developments have turned attention to Patanjali Foods, given its brand linkage and market visibility.
Patanjali Foods shares opened at ₹1,638.10 and, at the time of writing, hit an intraday high of ₹1,646.90, while the low stood at ₹1,625.60. Patanjali Foods is currently trading closer to its 52-week low of ₹1,541.05, significantly below its 52-week high of ₹2,011.00.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.